RVMD
Revolution Medicines Inc

1,034
Mkt Cap
$12.73B
Volume
2.66M
52W High
$66.00
52W Low
$29.17
PE Ratio
-12.71
RVMD Fundamentals
Price
$64.38
Prev Close
$65.83
Open
$65.53
50D MA
$50.14
Beta
1.16
Avg. Volume
2.15M
EPS (Annual)
-$3.58
P/B
7.82
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Revolution Medicines (NASDAQ:RVMD) Hits New 12-Month High - Time to Buy?
Revolution Medicines (NASDAQ:RVMD) Reaches New 52-Week High - Time to Buy...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Sold by Profund Advisors LLC
Profund Advisors LLC cut its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 14.1% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·13h ago
News Placeholder
S&CO Inc. Acquires 5,000 Shares of Revolution Medicines, Inc. $RVMD
S&CO Inc. raised its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 54.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·2d ago
News Placeholder
Fox Run Management L.L.C. Makes New Investment in Revolution Medicines, Inc. $RVMD
Fox Run Management L.L.C. bought a new position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC...
MarketBeat·3d ago
News Placeholder
Research Analysts Set Expectations for RVMD FY2025 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Stock analysts at Leerink Partnrs reduced their FY2025 earnings per share estimates for shares of Revolution Medicines in a research report...
MarketBeat·4d ago
News Placeholder
Equities Analysts Issue Forecasts for RVMD FY2025 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Equities research analysts at HC Wainwright lowered their FY2025 earnings estimates for shares of Revolution Medicines in a research report...
MarketBeat·4d ago
News Placeholder
Research Analysts Offer Predictions for RVMD FY2025 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Research analysts at Wedbush cut their FY2025 EPS estimates for shares of Revolution Medicines in a note issued to investors on Thursday...
MarketBeat·4d ago
News Placeholder
Research Analysts Issue Forecasts for RVMD FY2025 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Analysts at Lifesci Capital decreased their FY2025 earnings estimates for shares of Revolution Medicines in a research note issued on...
MarketBeat·4d ago
News Placeholder
JPMorgan Chase & Co. Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price
JPMorgan Chase & Co. upped their price target on Revolution Medicines from $71.00 to $82.00 and gave the stock an "overweight" rating in a report on Thursday...
MarketBeat·6d ago
News Placeholder
Revolution Medicines (NASDAQ:RVMD) Sets New 12-Month High After Analyst Upgrade
Revolution Medicines (NASDAQ:RVMD) Reaches New 52-Week High on Analyst Upgrade...
MarketBeat·6d ago

Latest RVMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.